Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Two companies in UCLPartners’ region selected to develop game changing technologies

19 October 2015

Two companies working within UCLPartners’ AHSN region have been selected for Phase 2 of the Small Business Research Initiative for Healthcare (SBRI Healthcare) clinically-led competition. The NHS England funded initiative helps develop innovative products that address unmet health needs.

From 26 companies awarded Phase 1 funding in December 2014, MIRA Rehab and Maldaba Ltd. were amongst 11 companies selected. The selection panel were looking for game-changing technologies that demonstrated best value and greatest technical feasibility. The companies specifically focused on addressing challenges in five key areas of healthcare: Child and Maternal Health; Integrated Care; Medicines Adherence; Musculoskeletal; and Telehealth/Telecare for people with Learning Disabilities.

Within the Musculoskeletal category, MIRA Rehab were selected to further develop their software platform. The system transforms existing physical therapy exercises into video-games, and uses an external sensor to track and assess patient compliance. It is designed to make physiotherapy fun and convenient for patients recovering from surgery or injury.

Maldaba Ltd. was selected for their work on My Health Guide. The guide is a collaboration between Maldaba and adult social care specialist Ken Pugh to develop a tablet optimized app. The app which documents the likes, dislikes, needs and challenges associated with caring for an individual with severe multiple physical and learning disabilities. The project builds on earlier work by Ken, and commissioned by Humber NHS Trust in which a bespoke iBook Matthew’s Book was developed for an individual user.

Professor Joanne Hackett (Director of Commercial Development, UCLPartners) said:
“UCLPartners is committed to the delivering the best solutions for our patients, and being involved with SBRI is helping us to achieve that. Defining an unmet clinical need, finding a solution, and diffusing it into the NHS is why we exist and work closely with colleagues at SBRI. We are delighted to have companies within our partnership securing funding and look forward to working with them on their journey.”

Both companies will now be supported and receive further funding of up to £1 million to continue with prototype development and product testing.

To find out more visit the SBRI website.